✦ LIBER ✦

INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer

✍ Scribed by Yi-Long Wu; Keunchil Park; Ross A Soo; Yan Sun; Karin Tyroller; David Wages; Guy Ely; James Chih-Hsin Yang; Tony Mok

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Multicenter Open-Label Study to Assess

✍ Charles Butts; R. Nevin Murray; Colum J. Smith; Peter M. Ellis; Kevin Jasas; And 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 115 KB

Updated survival analysis in patients wi

✍ Charles Butts; Andrew Maksymiuk; Glenwood Goss; Denis Soulières; Ernie Marshall; 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 225 KB

Phase I Study of the BLP25 (MUC1 Peptide

✍ Martin Palmer; Joanne Parker; Shanu Modi; Charlie Butts; Mike Smylie; Allison Me 📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 423 KB

Tecemotide (L-BLP25) versus placebo afte

✍ Butts, Charles; Socinski, Mark A; Mitchell, Paul L; Thatcher, Nick; Havel, Libor 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 546 KB

Commentary on “Phase I Study of the BLP2

✍ Kathy Schiffman; Mary L. Disis 📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 53 KB

O-083 A multicenter phase IIB randomized

✍ Butts, C. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB